G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain
- PMID: 2108241
G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain
Abstract
The serotonin 1b (5-HT1b) receptor is thought to mediate both pre- and postsynaptic actions of serotonin. Until recently 5-HT1b sites were thought to be present only in rodent brain. We now report the presence of high-affinity [125I]iodocyanopindolol [( 125I] ICYP) binding sites in the mouse renal medulla with properties identical to those of brain 5-HT1b receptors. In vitro receptor autoradiography demonstrates that [125I]ICYP binding is highly localized to the outer stripe of the renal medulla. Association and dissociation kinetics, saturation analysis and competition displacement analyses indicate that renal medullary [125I]ICYP binding sites exhibit identical properties with brain 5-HT1b receptors. Incubation of renal medullary or brain membranes with guanylimidodiphosphate results in a decreased affinity of 5-HT1b sites for 5-HT and [125I]ICYP; this can be reversed by the addition of a purified mixture of G proteins (Gi/Go). Treatment of brain or kidney membranes with N-ethylmaleimide results in a decrease in 5-HT1b binding which can also be restored by reconstitution with purified G proteins. Adenylyl cyclase from renal medullary homogenates or minces can be stimulated more than 3-fold by forskolin and attenuated by 5-HT. These results indicate that mouse kidney contains high-affinity 5-HT1b receptors with identical properties to those found in brain. These are localized in the outer stripe of the renal medulla and are functionally coupled to adenylyl cyclase inhibitor (Gi) G-proteins.
Similar articles
-
Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.J Pharmacol Exp Ther. 1988 Jan;244(1):144-53. J Pharmacol Exp Ther. 1988. PMID: 3335996
-
Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.Mol Pharmacol. 1988 Oct;34(4):527-36. Mol Pharmacol. 1988. PMID: 3139989
-
G protein dependent alterations in [125I]iodocyanopindolol and +/- cyanopindolol binding at 5-HT1B binding sites in rat brain membranes.Neurochem Res. 1989 Sep;14(9):835-43. doi: 10.1007/BF00964812. Neurochem Res. 1989. PMID: 2512511
-
The 5-HT1B receptors.Ann N Y Acad Sci. 1990;600:132-47; discussion 347-48. doi: 10.1111/j.1749-6632.1990.tb16878.x. Ann N Y Acad Sci. 1990. PMID: 2252306 Review.
-
Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype.Ann N Y Acad Sci. 1998 Dec 15;861:174-82. doi: 10.1111/j.1749-6632.1998.tb10189.x. Ann N Y Acad Sci. 1998. PMID: 9928255 Review.
Cited by
-
Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity.Mol Psychiatry. 2007 Nov;12(11):1042-56, 975. doi: 10.1038/sj.mp.4001990. Epub 2007 Apr 10. Mol Psychiatry. 2007. PMID: 17420766 Free PMC article.
-
Locally formed 5-hydroxytryptamine stimulates phosphate transport in cultured opossum kidney cells and in rat kidney.Biochem J. 1996 Dec 1;320 ( Pt 2)(Pt 2):615-21. doi: 10.1042/bj3200615. Biochem J. 1996. PMID: 8973575 Free PMC article.
-
5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells.Naunyn Schmiedebergs Arch Pharmacol. 1995 Sep;352(3):256-62. doi: 10.1007/BF00168555. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8584040
-
5-Hydroxytryptamine 5-HT1B receptors inhibiting cyclic AMP accumulation in rat renal mesangial cells.Naunyn Schmiedebergs Arch Pharmacol. 1995 Jan;351(1):35-9. doi: 10.1007/BF00169061. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7715739